Business Recovery

World

A New Axis Emerges: Meloni and Merz Forge Conservative Alliance, Diminishing Macron's Role in EU Leadership

Italian Prime Minister Giorgia Meloni and German Chancellor Friedrich Merz have signed a landmark partnership pact in Rome, signaling a potential shift in the European Union's traditional Franco-German power center. The accord, focusing on defense, migration, and trade, comes as France grapples with political instability and a weakened presidency.

Feb 2, 2026

World

Costa Rica Elects Laura Fernandez, Vowing Constitutional Overhaul and Crime Crackdown

Laura Fernandez, a close ally of outgoing populist President Rodrigo Chaves, has been elected Costa Rica's next leader. She pledges to continue his transformative agenda, including constitutional reforms and emergency measures to combat drug violence, signaling a profound shift for the nation.

Feb 2, 2026

Business

TAKKT AG's Three-Year Slump: Long-Term Shareholders Grapple with 68% Loss

Investors in German B2B specialist TAKKT AG (ETR:TTK) have faced a punishing three years, with total shareholder returns plummeting 68%. As revenue declines and the share price continues to slide, we examine the fundamentals behind the downturn and what it signals for the company's future.

Feb 2, 2026

Business

Small-Cap Surge: London's Overlooked Stocks Spark Investor Frenzy

As the FTSE 100 hits record highs, a broader rally in UK mid and small-cap indices is prompting a strategic rethink. Analysts debate whether these long-neglected shares, now showing historic undervaluation, are poised for a major comeback.

Feb 2, 2026

Business

Bitcoin's Fate Hinges on U.S. Labor Data and MicroStrategy Earnings This Week

As Bitcoin grapples with volatility below $80,000, a packed U.S. economic calendar—featuring key jobs reports and MicroStrategy's Q4 earnings—is poised to dictate the cryptocurrency's near-term trajectory by shaping Federal Reserve policy expectations.

Feb 2, 2026

Business

Order Book Battle: How Visible Liquidity Walls Held Bitcoin Back While Metals Soared

As gold and silver surged to record highs last month, Bitcoin's puzzling stagnation below $90,000 had traders searching for answers. A closer look at exchange order books reveals a deliberate play by large players to suppress price—a tactic that ultimately set the stage for last week's sharp decline.

Feb 2, 2026

Business

Three Stocks Poised for Growth as 2026 Investment Cycle Begins

As markets look ahead to 2026, a mix of established giants and emerging players in AI and digital advertising present compelling opportunities for investors seeking both growth and value.

Feb 2, 2026

Business

Stabilus Earnings: A Deeper Look Beyond the Headline Numbers

While Stabilus SE's recent profit figures appeared subdued, a closer examination reveals underlying strength and potential for a rebound, as the market's positive reaction suggests.

Feb 2, 2026

Business

Compagnie Financière Tradition Shares Soar 179% in Three Years, Outpacing Earnings Growth

The Swiss interdealer broker has delivered a stellar 213% total shareholder return since 2021, fueled by market confidence and robust dividends, despite recent slight pullback.

Feb 2, 2026

Business

Zixin Group Holdings Sees Promising ROCE Growth, Signaling Potential for Long-Term Value

The Singapore-listed food company has turned profitable after years of losses, with a 12% return on capital employed and a significant expansion in its capital base—key indicators watched by investors seeking compounding growth stocks.

Feb 2, 2026

Business

Acsion Ltd: A Deep Dive into the JSE-Listed Property Developer's Investment Merits

Amidst the allure of high-growth tech narratives, Acsion (JSE:ACS) presents a case for steady, profitable growth. With strong insider alignment and improving margins, does this property-focused stock warrant a closer look from discerning investors?

Feb 2, 2026

World

Thai Heartland Reckoning: Rural Voters Rethink Loyalties, Threatening Pheu Thai's Populist Dominance

In Thailand's crucial northeast, a profound political realignment is underway. Farmers, disillusioned by unmet promises and economic hardship, are abandoning decades of party loyalty to back individual candidates, testing the foundations of the Shinawatra family's political machine ahead of pivotal elections.

Feb 2, 2026

World

Thailand's Election: A Three-Way Battle for the Future

As Thailand heads to the polls, three major parties offer starkly different visions for the nation's path forward, from populist subsidies to structural reforms, setting the stage for a pivotal political contest.

Feb 2, 2026

Business

Pet Industry Investment: Can Niche Player Chewy Outpace Retail Giant Walmart?

As the pet care market expands, investors weigh the focused approach of Chewy against Walmart's diversified scale. While Chewy offers pure exposure, Walmart's broader ecosystem and advertising growth present a compelling alternative.

Feb 2, 2026

Business

iRhythm Completes Corporate Overhaul, Establishes New Holding Company Structure

Cardiac monitoring specialist iRhythm has finalized a significant corporate restructuring, creating a new parent company to serve as its publicly listed entity on Nasdaq. The move is seen as a strategic step to streamline governance and provide operational flexibility as the company expands its AI-driven health platform.

Feb 2, 2026

Business

Tandem Diabetes Care: A Value Play After Steep Decline, or Value Trap?

Shares of insulin pump maker Tandem Diabetes Care have plummeted over 80% in five years, trading near $20. A deep dive into valuation metrics suggests the stock may now be modestly undervalued, but significant risks and competitive pressures remain.

Feb 2, 2026

Business

PROG Holdings Stock Surge Puts Valuation in Spotlight: Momentum or Misalignment?

Shares of PROG Holdings (PRG) have rallied sharply in recent months, prompting investors to scrutinize whether the fintech company's current valuation reflects its underlying fundamentals or is simply riding a wave of market momentum.

Feb 2, 2026

Business

Travere Therapeutics Under Investigation: Legal Scrutiny Clouds Biotech's Path to Profitability

Travere Therapeutics faces a securities fraud investigation by Robbins Geller Rudman & Dowd LLP, raising questions about the accuracy of its past disclosures. The probe casts a shadow over the company's critical transition, as it banks on its kidney drug FILSPARI to drive growth amid mounting legal and commercial pressures.

Feb 2, 2026

Business

Tapestry's Valuation Puzzle: Is the Luxury Giant's Soaring Stock Price Justified?

After a staggering 75% surge over the past year, Tapestry's stock is under the microscope. While a discounted cash flow model suggests the shares are roughly fairly valued, its sky-high P/E ratio tells a more cautionary tale, raising questions about whether the market's optimism has gotten ahead of itself.

Feb 2, 2026

Business

Bitcoin's Slide Below $75K Puts MicroStrategy's Billion-Dollar Bet in the Red

A sharp correction in Bitcoin prices has pushed MicroStrategy's massive holdings into significant paper losses, testing the resolve of the corporate sector's most vocal crypto advocate and raising questions about the sustainability of its accumulation strategy.

Feb 2, 2026